BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19651603)

  • 1. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.
    Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13260-5. PubMed ID: 19651603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
    Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
    J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor.
    Liu X; Marmorstein R
    Genes Dev; 2007 Nov; 21(21):2711-6. PubMed ID: 17974914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of allostery by protein intrinsic disorder.
    Ferreon AC; Ferreon JC; Wright PE; Deniz AA
    Nature; 2013 Jun; 498(7454):390-4. PubMed ID: 23783631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR; Harlow E; Helin K
    Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
    Sandmöller A; Meents H; Arnold HH
    Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP.
    Pelka P; Ablack JN; Torchia J; Turnell AS; Grand RJ; Mymryk JS
    Nucleic Acids Res; 2009 Mar; 37(4):1095-106. PubMed ID: 19129215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus E1A proteins regulate phosphoenolpyruvate carboxykinase gene transcription through multiple mechanisms.
    Klemm DJ; Colton LA; Ryan S; Routes JM
    J Biol Chem; 1996 Apr; 271(14):8082-8. PubMed ID: 8626493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300.
    Fera D; Marmorstein R
    Biochemistry; 2012 Nov; 51(47):9524-34. PubMed ID: 23121466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
    Corbeil HB; Branton PE
    J Virol; 1994 Oct; 68(10):6697-709. PubMed ID: 8084002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
    De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
    J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.
    Vijayalingam S; Subramanian T; Zhao LJ; Chinnadurai G
    J Virol; 2016 Jan; 90(2):1070-9. PubMed ID: 26559831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle-mediated regulation of smooth muscle alpha-actin gene transcription in fibroblasts and vascular smooth muscle cells involves multiple adenovirus E1A-interacting cofactors.
    Wang SX; Elder PK; Zheng Y; Strauch AR; Kelm RJ
    J Biol Chem; 2005 Feb; 280(7):6204-14. PubMed ID: 15576380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
    Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction.
    Baluchamy S; Sankar N; Navaraj A; Moran E; Thimmapaya B
    Oncogene; 2007 Feb; 26(5):781-7. PubMed ID: 16862175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.